Trial capabilities key to enabling agility and speed in global study involving 44,000 subjects
Read the press releaseRecognises ICON’s long-standing vaccine development expertise.
Read the press releaseGlobal research network offering integrated solutions of patient assessments at site and in-home for decentralised trials
Read the press releaseICON recognised as top employer for women in anonymous survey of 75,000 employees
Read the press release